Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Date of Report: December 12, 2025
Key Event: The Company announced the implementation of a 1-for-10 reverse stock split of its common stock, approved by stockholders on October 16, 2025. The split is effective at 11:59 p.m. Eastern Time on December 15, 2025, with trading on a split-adjusted basis commencing on December 16, 2025.
Key Financial Metrics
The filing provides historical financial data adjusted for the reverse stock split. The Company is currently in a loss-making position.
| Metric | 12 Months Ended June 30, 2025 (Post-Split) | 12 Months Ended June 30, 2024 (Post-Split) | 3 Months Ended Sep 30, 2025 (Post-Split) | 3 Months Ended Sep 30, 2024 (Post-Split) |
|---|---|---|---|---|
| Net Loss | $(10,568,733) | $(10,156,759) | $(2,983,006) | $(2,685,633) |
| Weighted Avg Shares (Basic) | 527,365 | 159,275 | 854,694 | 381,109 |
| Loss Per Share (Basic) | $(20.04) | $(63.77) | $(3.49) | $(7.05) |
Capital Structure Impact: Outstanding shares will reduce from approximately 9,595,335 to 959,533. Authorized shares remain at 100 million. Par value remains $0.01. No fractional shares will be issued; cash will be paid in lieu of fractions.
Material Changes
- Share Count Reduction: The number of outstanding shares will decrease by approximately 90% immediately following the effective time.
- Per Share Metrics: Historical loss per share figures have been restated to reflect the 1-for-10 split, resulting in a tenfold increase in the reported loss per share value (e.g., from $(2.00) to $(20.04) for the 12 months ended June 30, 2025).
- Derivative Adjustments: Proportionate adjustments will be made to exercise prices and share counts for outstanding stock options, RSUs, and warrants.
Guidance, Outlook, and Risks
Management Commentary: The filing focuses on the mechanics of the reverse stock split and the amendment to the Certificate of Incorporation. It does not provide specific forward-looking financial guidance or operational outlook beyond the effective date of the split.
Risks and Contingencies:
- Fractional Shares: Shareholders holding fractional shares will receive cash in lieu of shares, calculated based on the average closing price of the five trading days preceding the split.
- Trading Symbol: The symbol remains "INBS," but the CUSIP number will change to 36151G709.
Investor Verification Checklist
- Verify the exact number of shares held and the cash amount due for any fractional shares resulting from the 1-for-10 split.
- Confirm the new CUSIP number (36151G709) for trading purposes starting December 16, 2025.
- Review the impact of the split on the exercise price and share count of any held stock options or warrants.
- Monitor the Company's liquidity and cash burn rate, as the filing indicates continued net losses without specific revenue generation details.